Effectiveness and safety of 30 mg versus 40 mg stavudine regimens: a cohort study among HIV-infected adults initiating HAART in South Africa

BACKGROUND: As stavudine remains an important and widely prescribed drug in resource-limited settings, the effect of a reduced dose of stavudine (from 40 mg to 30 mg) on outcomes of highly active antiretroviral therapy (HAART) remains an important public health question. METHODS: We analyzed prospec...

Descripción completa

Detalles Bibliográficos
Autores principales: Maskew, Mhairi, Westreich, Daniel, Fox, Matthew P, Maotoe, Thapelo, Sanne, Ian M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313885/
https://www.ncbi.nlm.nih.gov/pubmed/22410312
http://dx.doi.org/10.1186/1758-2652-15-13

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313885/
https://www.ncbi.nlm.nih.gov/pubmed/22410312
http://dx.doi.org/10.1186/1758-2652-15-13

Ejemplares similares